Review
Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia
Affiliations
- PMID: 10828757
Item in Clipboard
Review
Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia
Kidney Int Suppl.
2000 Apr.
Free article
Abstract
The question of why chronic renal diseases progress is a topic only recently investigated. Putative causes such as proteinuria do not account for all aspects of progressive renal disease. An alternative mechanism, chronic hypoxia, is proposed that might better explain certain elements of progressive renal disease, but elements of the hypothesis remain subject to further study.
Similar articles
-
Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.Clin J Am Soc Nephrol. 2006 Jul;1(4):730-7. doi: 10.2215/CJN.01110905. Epub 2006 May 17. Clin J Am Soc Nephrol. 2006. PMID: 17699280 Clinical Trial.
-
Relationship between proteinuria and progressive renal disease.Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S13-6. doi: 10.1053/ajkd.2001.20732. Am J Kidney Dis. 2001. PMID: 11158854
-
Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.Clin J Am Soc Nephrol. 2008 Jan;3 Suppl 1(Suppl 1):S17-23. doi: 10.2215/CJN.03270807. Clin J Am Soc Nephrol. 2008. PMID: 18178792 Free PMC article. Review.
-
Achieving maximal renal protection in nondiabetic chronic renal disease.Am J Kidney Dis. 2001 Dec;38(6):1365-71. doi: 10.1053/ajkd.2001.29259. Am J Kidney Dis. 2001. PMID: 11728976 Review.
-
Renal and cardiovascular effects of angiotensin-converting enzyme inhibitor plus angiotensin II receptor antagonist therapy in children with proteinuria.Pediatrics. 2006 Sep;118(3):e833-8. doi: 10.1542/peds.2005-2053. Epub 2006 Aug 21. Pediatrics. 2006. PMID: 16923922 Clinical Trial.
Cited by
-
Low oxygen stimulates the immune system.Kidney Int. 2008 Apr;73(7):797-9. doi: 10.1038/ki.2008.15. Kidney Int. 2008. PMID: 18340350 Free PMC article.
-
Predicted consequences of diabetes and SGLT inhibition on transport and oxygen consumption along a rat nephron.Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1269-83. doi: 10.1152/ajprenal.00543.2015. Epub 2016 Jan 13. Am J Physiol Renal Physiol. 2016. PMID: 26764207 Free PMC article.
-
Signalling pathways involved in hypoxia-induced renal fibrosis.J Cell Mol Med. 2017 Jul;21(7):1248-1259. doi: 10.1111/jcmm.13060. Epub 2017 Jan 18. J Cell Mol Med. 2017. PMID: 28097825 Free PMC article. Review.
-
Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.J Clin Invest. 2007 Dec;117(12):3810-20. doi: 10.1172/JCI30487. J Clin Invest. 2007. PMID: 18037992 Free PMC article.
-
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors.Drugs. 2022 Nov;82(16):1565-1589. doi: 10.1007/s40265-022-01783-3. Epub 2022 Nov 9. Drugs. 2022. PMID: 36350500 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
